Host Cell Protection from Complement by Glycosyl-phosphatidylinositol-Anchored Complement Inhibitors and Their Deficiencies in Paroxysmal Nocturnal Hemoglobinuria
Data up to Jan 2025
Total Citations Per Year
Abstract
References (55)
CELL-SURFACE ANCHORING OF PROTEINS VIA GLYCOSYL-PHOSPHATIDYLINOSITOL STRUCTURES
1988 • 1,284 citations
The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.
1988 • 654 citations
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
1982 • 603 citations
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
1984 • 571 citations
Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
1983 • 438 citations
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
1985 • 408 citations
Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
1989 • 407 citations
The Pi-linked receptor FcRIII is released on stimulation of neutrophils
1988 • 402 citations
The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria
1988 • 387 citations
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins
1987 • 359 citations
Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.
1986 • 358 citations
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.
1987 • 340 citations
Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
1983 • 324 citations
Structure-function relationships of the complement components
1989 • 311 citations
Paroxysmal Nocturnal Hemoglobinuria: Evidence for Monoclonal Origin of Abnormal Red Cells
1970 • 289 citations
Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid
1986 • 282 citations
Glycosyl‐phosphatidylinositol: a versatile anchor for cell surface proteins 1
1989 • 267 citations
Isolation from Human Erythrocytes of a New Membrane Protein Which Inhibits the Formation of Complement Transmembrane Channels1
1988 • 266 citations
Monocyte antigen CD14 is a phospholipid anchored membrane protein
1989 • 257 citations
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.
1987 • 256 citations
Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
1986 • 241 citations
Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
1986 • 240 citations
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
1987 • 205 citations
A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
1989 • 203 citations
Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.
1987 • 167 citations
Deficiency of the Complement Regulatory Protein, Decay-Accelerating Factor, on Membranes of Granulocytes, Monocytes, and Platelets in Paroxysmal Nocturnal Hemoglobinuria
1985 • 153 citations
Identification of human erythrocyte blood group antigens on decay- accelerating factor (DAF) and an erythrocyte phenotype negative for daf
1988 • 146 citations
Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system
1985 • 143 citations
Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol
1989 • 135 citations
Decay-accelerating factor is present on cultured human umbilical vein endothelial cells.
1986 • 129 citations
Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor.
1987 • 128 citations
Paroxysmal nocturnal haemoglobinuria
1992 • 117 citations
Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
1985 • 117 citations
Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
1987 • 113 citations
Paroxysmal Nocturnal Haemoglobinuria
1985 • 98 citations
Biochemical studies on leucocytes. II. Phosphatase activity in chronic lymphatic leucemia, acute leucemia, and miscellaneous hematologic conditions.
1951 • 97 citations
Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
1987 • 83 citations
Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.
1986 • 82 citations
Neutrophil (Leucocyte) Alkaline Phosphatase in Paroxysmal Nocturnal Haemoglobinuria
1965 • 79 citations
A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets.
1987 • 75 citations
Decay accelerating factor regulates complement activation on glomerular epithelial cells.
1989 • 67 citations
Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C
1988 • 62 citations
Erythrocyte Acetylcholinesterase Deficiency in Paroxysmal Nocturnal Hemoglobinuria (PNH)—A Comparison of the Complement-Sensitive and Insensitive Populations
1969 • 57 citations
Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
1985 • 53 citations
Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
1988 • 44 citations
The Molecular Basis of Target Cell Killing by Human Lymphocytes and of Killer Cell Self‐Protection
1988 • 40 citations
The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
1988 • 37 citations
Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C
1988 • 37 citations
Different distribution of decay-accelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria
1988 • 29 citations
Different distribution of decay-accelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria
1988 • 25 citations
Decay‐accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme‐linked immunosorbent assay (ELISA)
1988 • 24 citations
A high m.w. form of decay-accelerating factor (DAF-2) exhibits size abnormalities in paroxysmal nocturnal hemoglobinuria erythrocytes.
1987 • 24 citations
Not all in a name
1989 • 22 citations
Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.
1988 • 20 citations
Molecular Mechanisms of Cytotoxicity: Comparison of Complement and Killer Lymphocytes
1986 • 7 citations